Xeris Biopharma Holdings
XERS
XERS
86 hedge funds and large institutions have $85M invested in Xeris Biopharma Holdings in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 35 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
86
Holders Change
+19
Holders Change %
+28.36%
% of All Funds
1.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
29
Increased
35
Reduced
14
Closed
10
Calls
–
Puts
$685K
Net Calls
-$685K
Net Calls Change
-$684K
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$7.07M |
| 2 |
SM
2
Sabby Management
Miami Beach,
Florida
|
$2.89M |
| 3 |
3
Invesco
Atlanta,
Georgia
|
$5.33M |
| 4 |
SC
4
Sessa Capital
New York
|
$11.1M |
| 5 |
5
Millennium Management
New York
|
$1.34M |
Top Sellers
| 1 |
RG
1
Redmile Group
San Francisco,
California
|
$6.38M |
| 2 |
HP
2
Hound Partners
New York
|
$181K |
| 3 |
3
Blackstone Inc
New York
|
$0 |
| 4 |
4
Renaissance Technologies
New York
|
$279K |
| 5 |
DM
5
Deerfield Management
New York
|
$8.46M |
